The Role of Tumor Microenvironment in Pancreatic Cancer Immunotherapy: Current Status and Future Perspectives
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Pancreatic ductal adenocarcinoma (PDAC) remains deadly due to its complex tumor microenvironment (TME). Targeting the TME is crucial for improving immunotherapy efficacy and patient survival in pancreatic cancer.
Area Of Science
- Oncology
- Cancer Biology
- Immunotherapy
Background
- Pancreatic ductal adenocarcinoma (PDAC) is a highly lethal cancer with poor prognosis, often diagnosed at advanced stages.
- Current treatments, including immunotherapy, show limited efficacy, with only 13% of patients surviving beyond 5 years.
- The desmoplastic tumor microenvironment (TME) in PDAC hinders drug delivery and immune cell infiltration, creating 'cold' tumors resistant to therapy.
Purpose Of The Study
- To review the cellular and non-cellular components of the PDAC TME and their interactions.
- To discuss current therapeutic strategies for PDAC.
- To highlight future immunotherapy and multimodal treatment approaches focused on TME modulation.
Main Methods
- Literature review of PDAC tumor microenvironment.
- Analysis of current and emerging therapeutic strategies.
- Focus on immunotherapy and TME-remodeling treatments.
Main Results
- The PDAC TME is a significant barrier to effective treatment and immunotherapy.
- Understanding TME complexity is key to overcoming treatment resistance.
- Multimodal strategies targeting the TME show promise for enhancing therapeutic efficacy.
Conclusions
- Modulating the pancreatic cancer TME is essential for improving treatment outcomes.
- Future research should focus on novel immunotherapies and combination treatments that remodel the TME.
- Overcoming TME-induced resistance is critical for advancing pancreatic cancer therapy.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.